The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome

Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some bi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Marmara Medical Journal 2024-10, Vol.37 (3), p.295-299
Hauptverfasser: Çiçek, Neslihan, Gökçe, İbrahim, Güven, Serçin, Yaman, Ali, Alpay, Harika
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 299
container_issue 3
container_start_page 295
container_title Marmara Medical Journal
container_volume 37
creator Çiçek, Neslihan
Gökçe, İbrahim
Güven, Serçin
Yaman, Ali
Alpay, Harika
description Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some biomarkers in terms of predicting steroid response in patients with NS. Patients and Methods: Twenty patients who met the inclusion criteria for the study were divided into 3 groups and 6 healthy control participants were included in the analysis as the 4th group. Group-1 included 10 patients at the first episode of idiopathic NS (INS), group-2 included the same 10 patients in remission, group-3 included 10 patients with steroid resistant NS (SRNS) diagnosed as FSGS by renal biopsy, and group-4 included six healthy children as controls. Urinary and serum cluster of differentiation (CD) CD80, IL-17, IL-23, IL-10, TGF-β, CD86, CD28, CTLA-4 levels were measured for all groups. Results: Urinary CD80 level in INS-relapse group was significantly higher than the levels of the INS-remission, FSGS and control groups (p
doi_str_mv 10.5472/marumj.1571937
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3128523054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3128523054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c674-b37f328b4729ed6213cf214df886152a8d409f9bbcdc9727121e1bed1f62bf343</originalsourceid><addsrcrecordid>eNotkL1PwzAUxC0EEqWwMltiTvGznTgeUcWXVImlYrUS-1l1aeNgO0P_e4La6W443Xv3I-QR2KqWij8fuzQd9yuoFWihrsgCBNOVlo2-nj0DXYGWcEvuct4zVrdMNwvyvd0hnUo4hHKi0dM-xLnnB1OmJdIxoQu20FwwxeBowjzGISMNAw0uxLEru2DpgOMuxTK7fBpcike8Jze-O2R8uOiSbN9et-uPavP1_rl-2VS2UbLqhfKCt_38vUbXcBDWc5DOt20DNe9aJ5n2uu-ts1pxBRwQenTgG957IcWSPJ1rxxR_J8zF7OOUhvmiEcDbmgtW_6dW55RNMeeE3owpzCtPBpj5R2fO6MwFnfgDtv5kGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128523054</pqid></control><display><type>article</type><title>The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Çiçek, Neslihan ; Gökçe, İbrahim ; Güven, Serçin ; Yaman, Ali ; Alpay, Harika</creator><creatorcontrib>Çiçek, Neslihan ; Gökçe, İbrahim ; Güven, Serçin ; Yaman, Ali ; Alpay, Harika</creatorcontrib><description>Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some biomarkers in terms of predicting steroid response in patients with NS. Patients and Methods: Twenty patients who met the inclusion criteria for the study were divided into 3 groups and 6 healthy control participants were included in the analysis as the 4th group. Group-1 included 10 patients at the first episode of idiopathic NS (INS), group-2 included the same 10 patients in remission, group-3 included 10 patients with steroid resistant NS (SRNS) diagnosed as FSGS by renal biopsy, and group-4 included six healthy children as controls. Urinary and serum cluster of differentiation (CD) CD80, IL-17, IL-23, IL-10, TGF-β, CD86, CD28, CTLA-4 levels were measured for all groups. Results: Urinary CD80 level in INS-relapse group was significantly higher than the levels of the INS-remission, FSGS and control groups (p</description><identifier>ISSN: 1019-1941</identifier><identifier>EISSN: 1309-9469</identifier><identifier>DOI: 10.5472/marumj.1571937</identifier><language>eng</language><publisher>Istanbul: Marmara University</publisher><subject>Biomarkers ; Kidney diseases ; Remission (Medicine) ; Steroids</subject><ispartof>Marmara Medical Journal, 2024-10, Vol.37 (3), p.295-299</ispartof><rights>2024. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://dergipark.org.tr/en/pub/marumj/about-journal</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c674-b37f328b4729ed6213cf214df886152a8d409f9bbcdc9727121e1bed1f62bf343</cites><orcidid>0000-0002-6896-5162 ; 0000-0003-3284-9204 ; 0000-0002-5859-4177 ; 0000-0001-5659-5195 ; 0000-0002-0850-1964</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Çiçek, Neslihan</creatorcontrib><creatorcontrib>Gökçe, İbrahim</creatorcontrib><creatorcontrib>Güven, Serçin</creatorcontrib><creatorcontrib>Yaman, Ali</creatorcontrib><creatorcontrib>Alpay, Harika</creatorcontrib><title>The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome</title><title>Marmara Medical Journal</title><description>Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some biomarkers in terms of predicting steroid response in patients with NS. Patients and Methods: Twenty patients who met the inclusion criteria for the study were divided into 3 groups and 6 healthy control participants were included in the analysis as the 4th group. Group-1 included 10 patients at the first episode of idiopathic NS (INS), group-2 included the same 10 patients in remission, group-3 included 10 patients with steroid resistant NS (SRNS) diagnosed as FSGS by renal biopsy, and group-4 included six healthy children as controls. Urinary and serum cluster of differentiation (CD) CD80, IL-17, IL-23, IL-10, TGF-β, CD86, CD28, CTLA-4 levels were measured for all groups. Results: Urinary CD80 level in INS-relapse group was significantly higher than the levels of the INS-remission, FSGS and control groups (p</description><subject>Biomarkers</subject><subject>Kidney diseases</subject><subject>Remission (Medicine)</subject><subject>Steroids</subject><issn>1019-1941</issn><issn>1309-9469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNotkL1PwzAUxC0EEqWwMltiTvGznTgeUcWXVImlYrUS-1l1aeNgO0P_e4La6W443Xv3I-QR2KqWij8fuzQd9yuoFWihrsgCBNOVlo2-nj0DXYGWcEvuct4zVrdMNwvyvd0hnUo4hHKi0dM-xLnnB1OmJdIxoQu20FwwxeBowjzGISMNAw0uxLEru2DpgOMuxTK7fBpcike8Jze-O2R8uOiSbN9et-uPavP1_rl-2VS2UbLqhfKCt_38vUbXcBDWc5DOt20DNe9aJ5n2uu-ts1pxBRwQenTgG957IcWSPJ1rxxR_J8zF7OOUhvmiEcDbmgtW_6dW55RNMeeE3owpzCtPBpj5R2fO6MwFnfgDtv5kGQ</recordid><startdate>20241030</startdate><enddate>20241030</enddate><creator>Çiçek, Neslihan</creator><creator>Gökçe, İbrahim</creator><creator>Güven, Serçin</creator><creator>Yaman, Ali</creator><creator>Alpay, Harika</creator><general>Marmara University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-6896-5162</orcidid><orcidid>https://orcid.org/0000-0003-3284-9204</orcidid><orcidid>https://orcid.org/0000-0002-5859-4177</orcidid><orcidid>https://orcid.org/0000-0001-5659-5195</orcidid><orcidid>https://orcid.org/0000-0002-0850-1964</orcidid></search><sort><creationdate>20241030</creationdate><title>The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome</title><author>Çiçek, Neslihan ; Gökçe, İbrahim ; Güven, Serçin ; Yaman, Ali ; Alpay, Harika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c674-b37f328b4729ed6213cf214df886152a8d409f9bbcdc9727121e1bed1f62bf343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarkers</topic><topic>Kidney diseases</topic><topic>Remission (Medicine)</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Çiçek, Neslihan</creatorcontrib><creatorcontrib>Gökçe, İbrahim</creatorcontrib><creatorcontrib>Güven, Serçin</creatorcontrib><creatorcontrib>Yaman, Ali</creatorcontrib><creatorcontrib>Alpay, Harika</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Marmara Medical Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Çiçek, Neslihan</au><au>Gökçe, İbrahim</au><au>Güven, Serçin</au><au>Yaman, Ali</au><au>Alpay, Harika</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome</atitle><jtitle>Marmara Medical Journal</jtitle><date>2024-10-30</date><risdate>2024</risdate><volume>37</volume><issue>3</issue><spage>295</spage><epage>299</epage><pages>295-299</pages><issn>1019-1941</issn><eissn>1309-9469</eissn><abstract>Objective: The most common form of nephrotic syndrome (NS) is minimal change disease (MCD) in children and focal segmental glomerulosclerosis (FSGS) following it. As, it is important to predict corticosteroid (CS) response at the beginning of the disease, we aimed to evaluate the efficacy of some biomarkers in terms of predicting steroid response in patients with NS. Patients and Methods: Twenty patients who met the inclusion criteria for the study were divided into 3 groups and 6 healthy control participants were included in the analysis as the 4th group. Group-1 included 10 patients at the first episode of idiopathic NS (INS), group-2 included the same 10 patients in remission, group-3 included 10 patients with steroid resistant NS (SRNS) diagnosed as FSGS by renal biopsy, and group-4 included six healthy children as controls. Urinary and serum cluster of differentiation (CD) CD80, IL-17, IL-23, IL-10, TGF-β, CD86, CD28, CTLA-4 levels were measured for all groups. Results: Urinary CD80 level in INS-relapse group was significantly higher than the levels of the INS-remission, FSGS and control groups (p</abstract><cop>Istanbul</cop><pub>Marmara University</pub><doi>10.5472/marumj.1571937</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-6896-5162</orcidid><orcidid>https://orcid.org/0000-0003-3284-9204</orcidid><orcidid>https://orcid.org/0000-0002-5859-4177</orcidid><orcidid>https://orcid.org/0000-0001-5659-5195</orcidid><orcidid>https://orcid.org/0000-0002-0850-1964</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1019-1941
ispartof Marmara Medical Journal, 2024-10, Vol.37 (3), p.295-299
issn 1019-1941
1309-9469
language eng
recordid cdi_proquest_journals_3128523054
source EZB-FREE-00999 freely available EZB journals
subjects Biomarkers
Kidney diseases
Remission (Medicine)
Steroids
title The utility of biomarkers to predict steroid response in idiopathic nephrotic syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T09%3A49%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20utility%20of%20biomarkers%20to%20predict%20steroid%20response%20in%20idiopathic%20nephrotic%20syndrome&rft.jtitle=Marmara%20Medical%20Journal&rft.au=%C3%87i%C3%A7ek,%20Neslihan&rft.date=2024-10-30&rft.volume=37&rft.issue=3&rft.spage=295&rft.epage=299&rft.pages=295-299&rft.issn=1019-1941&rft.eissn=1309-9469&rft_id=info:doi/10.5472/marumj.1571937&rft_dat=%3Cproquest_cross%3E3128523054%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3128523054&rft_id=info:pmid/&rfr_iscdi=true